Skyepharma Competitors and Similar CompaniesClear all
Skyepharma's competitors and similar companies include Amicus Therapeutics.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ||
Founding Date | Founding Date 1996 | Founding Date 2002 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 2453% increase | Employees 58415% increase |
Financial | ||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit $561.3m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Amicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company